Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene Analysis & Biostatistics – 3 Is Better Than 2 But Not Than 4

17.07.2007
Three-stage procedures offer an optimal relationship between costs and benefits in analysing genetic influences in diseases and therapies, a fact that has major practical importance for the ever growing number of gene analyses.

This finding from a current project by the Austrian Science Fund FWF was presented at the 5th International Conference on Multiple Comparison Procedures (MCP2007) in Vienna, which recently drew to a close. The conference, held at the Medical University, focused on the increasingly important issue of boosting the efficiency of medical studies in statistical terms.

30,000 – this is the number of genes that can be analysed simultaneously with state-of-the-art instruments. Such analyses provide a means of identifying whether individual genes have a decisive impact in the course of a disease or therapy. However, the more genes that are examined in a study, the greater the probability of incorrectly identifying a gene as a factor when, in reality, it has no influence.

MORE CONCENTRATION – LESS ERRORS

... more about:
»Medical »Result »method

Dr. Sonja Zehetmayer from the Department of Medical Statistics, Medical University of Vienna, says: "The problem of identifying factors incorrectly could be countered by a very high number of repetition. However, repetition normally needs to be kept to a minimum, owing to high costs. A more innovative approach to solve this problem is offered by multi-stage methods. These involve preselecting genes following the first examination stage. In subsequent stages, only these selected genes are subject to further analysis. Concentrating on fewer genes thereby cuts error probability."

The question of exactly how many stages are needed to deliver an optimal cost-benefit ratio has until now remained unresolved. The answer has now been calculated, published, and discussed by Dr. Zehetmayer and her colleagues at the MCP2007 held in Vienna from 8 to 11 July. In actual fact, the solution turned out to be unexpectedly straightforward – three stages deliver the optimal ratio between the accuracy of the results obtained and the costs necessary for this. Although a fourth stage would offer greater accuracy, the resources this would require are out of all proportion to the additional accuracy gained.

TEST DESIGN

Dr. Zehetmayer also found surprising results when she compared two different test designs with each other: "Multi-stage series of tests can be analysed either by integrating the results of all levels or by analysing the results of only the last stage. While the choice of test design for four-stage methods has a marked effect on its statistical characteristics, this effect is mitigated in the case of a three-stage method."

Dr. Zehetmayer’s colleague Alexandra Goll presented a further aspect contributing to the optimum configuration of test methods at the MCP2007. She showed that the individual stages of multi-stage test methods can be configured very differently without having a major detrimental effect on the accuracy of the end result. This means that initial stages can clearly be more cost-effective if more accurate and more expensive methods are used for the following stages (involving fewer genes).

There is good reason why the latest trends in the statistical analysis of clinical data are being initiated and analysed at the Department of Medical Studies at the Medical University of Vienna. Prof. Peter Bauer published a paper there in 1989 refuting a basic principle of biostatistics that the test design in an ongoing study must not be changed until the end. This evidence is and remains the basis for multi-stage adaptive analytical methods that have recently attracted worldwide research interest due to cost pressures in healthcare and are supported by the FWF in Austria.

Image and text will be available online from Monday, 16th July 2007, 09.00 a.m. CET onwards:

http://www.fwf.ac.at/en/public_relations/press/pv200707-en.html

Till C. Jelitto | alfa
Further information:
http://www.fwf.ac.at/en/public_relations/press/pv200707-en.html

Further reports about: Medical Result method

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>